• 1
    Mosmann, T. R., Cherwinski, H., Bond, M. W., Giedlin, M. A. and Coffman, R. L., Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J. Immunol. 1986. 136: 23482357.
  • 2
    Sher, A., Gazzinelli, R. T., Oswald, I. P., Clerici, M., Kullberg, M., Pearce, E. J., Berzofsky, J. A., Mosmann, T. R., James, S. L.and Morse, H. C., 3rd, Role of T cell derived cytokines in the downregulation of immune responses in parasitic and retroviral infection. Immunol. Rev. 1992. 127: 183204.
  • 3
    Seder, R. A. and Paul, W. E., Acquisition of lymphokine-producing phenotype by CD4+ T cells. Annu. Rev.Immunol. 1994. 12: 635673.
  • 4
    Murphy, K. M., Ouyang, W., Farrar, J. D., Yang, J., Ranganath, S., Asnagli, H., Afkarian, M. and Murphy, T. L., Signaling and transcription in T helper development. Annu. Rev. Immunol. 2000. 18: 451494.
  • 5
    O'Garra, A., Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity 1998. 8: 275283.
  • 6
    Gordon, S., Alternative activation of macrophages. Nat. Rev. Immunol. 2003. 3: 2335.
  • 7
    Jankovic, D., Kullberg, M. C., Hieny, S., Caspar, P., Collazo, C. M. and Sher, A., In the absence of IL-12, CD4(+) T cell responses to intracellular pathogens fail to default to a Th2 pattern and are host protective in an IL-10(–/–) setting. Immunity 2002. 16: 429439.
  • 8
    Wegmann, T. G., Lin, H., Guilbert, L. and Mosmann, T. R., Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol. Today 1993. 14: 353356.
  • 9
    Lin, H., Mosmann, T. R., Guilbert, L., Tuntipopipat, S. and Wegmann, T. G., Synthesis of T helper 2-type cytokines at the maternal-fetal interface. J. Immunol. 1993. 151: 45624573.
  • 10
    Horne, C. H., Towler, C. M., Pugh-Humphreys, R. G., Thomson, A. W. and Bohn, H., Pregnancy specific beta1-glycoprotein – a product of the syncytiotrophoblast. Experientia 1976. 32: 1197.
  • 11
    Watanabe, S. and Chou, J. Y., Isolation and characterization of complementary DNAs encoding human pregnancy-specific beta 1-glycoprotein. J. Biol. Chem. 1988. 263: 20492054.
  • 12
    Zhou, G. Q., Baranov, V., Zimmermann, W., Grunert, F., Erhard, B., Mincheva-Nilsson, L., Hammarstrom, S. and Thompson, J., Highly specific monoclonal antibody demonstrates that pregnancy-specific glycoprotein (PSG) is limited to syncytiotrophoblast in human early and term placenta. Placenta 1997. 18: 491501.
  • 13
    Masson, G. M., Anthony, F. and Wilson, M. S., Value of Schwangerschaftsprotein 1 (SP1) and pregnancy-associated plasma protein-A (PAPP-A) in the clinical management of threatened abortion. Br. J. Obstet. Gynaecol. 1983. 90: 146149.
  • 14
    Silver, R. M., Heyborne, K. D. and Leslie, K. K., Pregnancy specific beta 1 glycoprotein (SP-1)in maternal serum and amniotic fluid; pre-eclampsia, small for gestational age fetus and fetal distress. Placenta 1993. 14: 583589.
  • 15
    Motran, C. C., Diaz, F. L., Gruppi, A., Slavin, D., Chatton,B. and Bocco, J. L., Human pregnancy-specific glycoprotein 1a (PSG1a) induces alternative activation in human and mouse monocytes and suppresses theaccessory cell-dependent T cell proliferation. J. Leukoc. Biol. 2002. 72: 512521.
  • 16
    Snyder, S. K., Wessner, D. H., Wessells, J. L., Waterhouse, R. M., Wahl, L. M., Zimmermann, W. and Dveksler, G. S., Pregnancy-specific glycoproteins function as immunomodulators by inducing secretion of IL-10, IL-6 and TGF-beta1 by human monocytes. Am. J. Reprod. Immunol. 2001. 45: 205216.
  • 17
    Wessells, J., Wessner, D., Parsells, R., White, K., Finkenzeller, D., Zimmermann, W. and Dveksler, G., Pregnancy specific glycoprotein 18 induces IL-10 expression in murine macrophages. Eur. J. Immunol. 2000. 30: 18301840.
  • 18
    Yip, H. C., Karulin, A. Y., Tary-Lehmann, M., Hesse, M. D., Radeke, H., Heeger, P. S., Trezza, R. P., Heinzel, F. P., Forsthuber, T. and Lehmann, P. V., Adjuvant-guided type-1 and type-2 immunity: infectious/noninfectious dichotomy defines the class of response. J. Immunol. 1999. 162: 39423949.
  • 19
    Lee, H. J., Takemoto, N., Kurata, H., Kamogawa, Y., Miyatake, S., O'Garra, A. and Arai, N., GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J. Exp. Med. 2000. 192: 105115.
  • 20
    Moore, K. W., de Waal Malefyt, R., Coffman, R. L. and O'Garra, A., Interleukin-10 and the interleukin-10 receptor. Annu. Rev. Immunol. 2001. 19: 683765.
  • 21
    King, C., Davies, J., Mueller, R., Lee, M. S., Krahl, T., Yeung, B., O'Connor, E. and Sarvetnick, N., TGF-beta1 alters APC preference, polarizing islet antigen responses toward a Th2 phenotype. Immunity 1998. 8: 601613.
  • 22
    Letterio, J. J. and Roberts, A. B., Regulation of immune responses by TGF-beta. Annu. Rev. Immunol. 1998. 16: 137161.
  • 23
    Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J. and Hill, A. M., M-1/M-2 macrophages and the Th1/Th2 paradigm. J. Immunol. 2000. 164: 61666173.
  • 24
    Kovarik, J., Gaillard, M., Martinez, X., Bozzotti, P., Lambert, P. H., Wild, T. F. and Siegrist, C. A., Induction of adult-like antibody, Th1, and CTL responses to measles hemagglutinin by early life murine immunization with an attenuated vaccinia-derived NYVAC(K1L) viral vector. Virology 2001. 285: 1220.
  • 25
    Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen-presenting cells. Immunity 1999. 10: 137142.
  • 26
    Perrin, G. Q., Johnson, H. M. and Subramaniam, P. S., Mechanism of interleukin-10 inhibition ofT-helper cell activation by superantigen at the level of the cell cycle. Blood 1999. 93: 208216.
  • 27
    Ouyang, W., Ranganath, S. H., Weindel, K., Bhattacharya, D., Murphy, T. L., Sha, W. C. and Murphy, K. M., Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity 1998. 9: 745755.
  • 28
    Matzinger, P., Tolerance, danger, and the extended family. Annu. Rev. Immunol. 1994. 12: 9911045.
  • 29
    Loke, P., MacDonald, A. S. and Allen, J. E., Antigen-presenting cells recruited by Brugia malayi induce Th2 differentiation of naive CD4(+) T cells. Eur. J. Immunol. 2000. 30: 11271135.
  • 30
    Gratchev, A., Schledzewski, K., Guillot, P. and Goerdt, S., Alternatively activated antigen-presenting cells: molecular repertoire, immune regulation, and healing. Skin Pharmacol. Appl. Skin Physiol. 2001. 14: 272279.
  • 31
    Bloom, B. R., Salgame, P. and Diamond, B., Revisiting and revising suppressor T cells. Immunol. Today 1992. 13: 131136.
  • 32
    Shiraishi, H., Hayakawa, S. and Satoh, K., Murine experimental abortion by IL-2 administration is caused by activation of cytotoxic T lymphocytes and placental apoptosis. J. Clin. Lab. Immunol. 1996. 48: 93108.
  • 33
    Chaouat, G., Tranchot Diallo, J., Volumenie, J. L., Menu, E., Gras, G., Delage, G. and Mognetti, B., Immune suppression and Th1/Th2 balance in pregnancy revisited: a (very) personaltribute to Tom Wegmann. Am. J. Reprod. Immunol. 1997. 37: 427434.
  • 34
    Sacks, G., Sargent, I. and Redman, C., An innate view of human pregnancy. Immunol. Today 1999. 20: 114118.
  • 35
    Nicoletti, I., Migliorati, G., Pagliacci, M. C., Grignani, F. and Riccardi, C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry. J. Immunol. Methods 1991. 139: 271279.
  • 36
    Corraliza, I. M., Campo, M. L., Soler, G. and Modolell, M., Determination of arginase activity in macrophages: a micromethod. J. Immunol. Methods 1994. 174: 231235.